The effects of interval walking training on development of sarcopenia in patients with chronic liver disease.

The effects of interval walking training on development of sarcopenia in patients with chronic liver disease. - The effects of interval walking training on patients with chronic liver disease.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036486

Enrollment

200

Registered

2019-04-12

Start date

2019-01-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic liver disease

Interventions

interval walking training for 6 M Control for 6 M

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: In patients with chronic type C hepatitis or compensated cirrhosis and non alcoholic fatty liver disease, who agrees to do interval walking training (interval walking training group) and who does not agree to do interval walking training (control group).

Exclusion criteria

Exclusion criteria: 1.Patient who is not suitable for doing interval walking training. 2.Patient who experienced cardiovascular disease, peripheral circulatory disease or cerebrovascular disease. 3.Patient with HCC

Design outcomes

Primary

Measure	Time frame
Reduction ratio of smooth muscle volume per year	—

Countries

Japan

Contacts

Public ContactKiyohide Kioka

Osaka City General Hospital Department of Hepatology

OCGH-NR@osakacity-hp.or.jp06-6929-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026